218 related articles for article (PubMed ID: 17651539)
21. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
22. Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.
Ehrich EW; Bolognese JA; Watson DJ; Kong SX
Am J Manag Care; 2001 Jun; 7(6):609-16. PubMed ID: 11439734
[TBL] [Abstract][Full Text] [Related]
23. Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study.
Haglund B; von Bültzingslöwen I
Eur J Oral Sci; 2006 Aug; 114(4):293-301. PubMed ID: 16911100
[TBL] [Abstract][Full Text] [Related]
24. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
Smugar SS; Schnitzer TJ; Weaver AL; Rubin BR; Polis AB; Tershakovec AM
Curr Med Res Opin; 2006 Jul; 22(7):1353-67. PubMed ID: 16834834
[TBL] [Abstract][Full Text] [Related]
25. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.
Price D; Stein B; Sieber P; Tutrone R; Bailen J; Goluboff E; Burzon D; Bostwick D; Steiner M
J Urol; 2006 Sep; 176(3):965-70; discussion 970-1. PubMed ID: 16890670
[TBL] [Abstract][Full Text] [Related]
26. Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999-2002.
Bottone FG; Barry WT
Curr Med Res Opin; 2009 Jun; 25(6):1535-50. PubMed ID: 19453292
[TBL] [Abstract][Full Text] [Related]
27. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group.
Hawkey C; Laine L; Simon T; Beaulieu A; Maldonado-Cocco J; Acevedo E; Shahane A; Quan H; Bolognese J; Mortensen E
Arthritis Rheum; 2000 Feb; 43(2):370-7. PubMed ID: 10693877
[TBL] [Abstract][Full Text] [Related]
30. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
31. Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery *.
Moore PA; Brar P; Smiga ER; Costello BJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):E1-7. PubMed ID: 15660075
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
Kivitz AJ; Greenwald MW; Cohen SB; Polis AB; Najarian DK; Dixon ME; Moidel RA; Green JA; Baraf HS; Petruschke RA; Matsumoto AK; Geba GP;
J Am Geriatr Soc; 2004 May; 52(5):666-74. PubMed ID: 15086644
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
Reiff A; Lovell DJ; Adelsberg JV; Kiss MH; Goodman S; Zavaler MF; Chen PY; Bolognese JA; Cavanaugh P; Reicin AS; Giannini EH
J Rheumatol; 2006 May; 33(5):985-95. PubMed ID: 16583464
[TBL] [Abstract][Full Text] [Related]
34. Comparison of adjunctive use of rofecoxib versus ibuprofen in the management of postoperative pain after uterine artery embolization.
Hovsepian DM; Mandava A; Pilgram TK; Holder AP; Wong V; Chan P; Patel T
J Vasc Interv Radiol; 2006 Apr; 17(4):665-70. PubMed ID: 16614150
[TBL] [Abstract][Full Text] [Related]
35. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
Biancone L; Tosti C; Geremia A; Fina D; Petruzziello C; Emerenziani S; Pallone F
Aliment Pharmacol Ther; 2004 Apr; 19(7):755-64. PubMed ID: 15043516
[TBL] [Abstract][Full Text] [Related]
36. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.
Stevenson DD; Simon RA
J Allergy Clin Immunol; 2001 Jul; 108(1):47-51. PubMed ID: 11447381
[TBL] [Abstract][Full Text] [Related]
37. Rofecoxib for rheumatoid arthritis.
Garner SE; Fidan DD; Frankish RR; Judd MG; Towheed TE; Wells G; Tugwell P
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD003685. PubMed ID: 15674912
[TBL] [Abstract][Full Text] [Related]
38. Rofecoxib administration to paediatric patients undergoing adenotonsillectomy.
Sheeran PW; Rose JB; Fazi LM; Chiavacci R; McCormick L
Paediatr Anaesth; 2004 Jul; 14(7):579-83. PubMed ID: 15200656
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004].
Sawicki PT; Bender R; Selke GW; Klauber J; Gutschmidt S
Med Klin (Munich); 2006 Mar; 101(3):191-7. PubMed ID: 16648975
[TBL] [Abstract][Full Text] [Related]
40. Does preoperative rofecoxib (Vioxx) decrease postoperative pain with laparoscopic cholecystectomy?
Horattas MC; Evans S; Sloan-Stakleff KD; Lee C; Snoke JW
Am J Surg; 2004 Sep; 188(3):271-6. PubMed ID: 15450833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
